Board of Directors
Michael Rice
Mike Rice became president and chief executive officer and a member of our board of directors in August 2006, and Chairman in August 2007. He has more than 20 years of leadership and entrepreneurial experience in the medical and high tech industries. He was most recently the senior business development manager for medical and wireless products at AMI Semiconductor (NASDAQ:AMIS). Mr. Rice also served as the director of marketing and business development at Cardiac Science, Inc. (NASDAQ:CSCX), a manufacturer of automated external defibrillators. Prior to that, he was the Vice President, Sales and Marketing for TEGRIS Corporation, a privately held network services provider. Mr. Rice also spent 12 years at Physio Control Corporation in several sales and marketing management roles prior to its acquisition by Medtronic Inc.
Howard S. Breslow
Howard S. Breslow has served as a director of the Company since
July 1988. He has been a practicing attorney in New York City
for more than 40 years and is a member of the law firm of
Breslow & Walker, LLP, New York, New York, which firm serves as
general counsel to the Company.
Roderick de Greef
Roderick de Greef has served as a director of the Company since
June 19, 2000. From March 2001 to September 2005, Mr. de Greef
has served as Executive Vice President, Chief Financial Officer
and Secretary of Cardiac Sciences, Inc. (NASDAQ: CSCX). In
October 2005, Mr. de Greef became the Chief Financial Officer of
Cambridge Heart, Inc., a medical device manufacturer located in
Bedford, MA. Since 1995, Mr. de Greef has provided corporate
finance advisory services to a number of early-stage companies,
including the Company, where he was instrumental in securing the
Company’s equity capital beginning in June 2000, and advising on
merger and acquisition activity. From 1989 to 1995, Mr. de Greef
was Vice President and Chief Financial Officer of BioAnalogics,
Inc. and International BioAnalogics, Inc., publicly held,
development stage medical technology companies located in
Portland, Oregon. From 1986 to 1989, Mr. de Greef was Controller
and then Chief Financial Officer of Brentwood Instruments, Inc.,
a publicly held cardiology products distribution company based
in Torrance, California. Mr. de Greef has a B.A. in Economics
and International Relations from California State University at
San Francisco and an MBA from the University of Oregon.
Thomas Girschweiler
Thomas Girschweiler joined the Board in 2003. Mr. Girschweiler has been engaged in corporate financing activities on his own behalf since 1996. From 1981 to 1996 he was an investment banker with Union Bank of Switzerland. Mr. Girschweiler was graduated at the Swiss Banking School.
Raymond Cohen
Raymond Cohen joined the Board in May 2006. Mr. Cohen
currently serves as Chief Executive Officer of Laguna Hills,
CA-based Symphony Medical, Inc., a venture capital backed
privately-held developer of biologic solutions for the treatment
of cardiac conduction abnormalities. Mr. Cohen is also a
director of Cardiac Science Corporation (NASDAQ: CSCX), where
he served as Chief Executive Officer for nine years, and as
Chairman from September 2005 through October 2006. Mr. Cohen
also serves as a member of the Board of Directors of Syncroness,
Inc., a privately-held contract engineering and product
development firm based in Westminster, CO. He is a member of the
Advisory Board for the College of Osteopathic Medicine, Western
University of Health Sciences in Pomona, CA.
Andrew Hinson
Andrew Hinson joined the Board in February 2007. He is currently
the Vice President for Clinical and Regulatory Affairs for
Symphony Medical, Inc., a developer of proprietary biopolymer
and cellular-based biologic therapies to effectively treat
chronic and post-operative atrial fibrillation and other cardiac
conduction abnormalities. Mr. Hinson has diverse experience in
the cell and gene therapy markets and extensive experience
managing clinical trials for new biologic based therapies for
cardiac, neurologic, and gastrointestinal applications.